Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis

AIMS: Type 2 diabetes (T2DM) in patients with coronavirus disease-19 (COVID-19) is associated with a worse prognosis. We separately investigated the associations between the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1 RA), and dipeptidy...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrannini, Giulia, Lund, Lars H, Benson, Lina, Rizzo, Manfredi, Almahmeed, Wael, Rosano, Giuseppe M C, Savarese, Gianluigi, Cosentino, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384777/
https://www.ncbi.nlm.nih.gov/pubmed/35963647
http://dx.doi.org/10.1093/ehjcvp/pvac044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384777/
https://www.ncbi.nlm.nih.gov/pubmed/35963647
http://dx.doi.org/10.1093/ehjcvp/pvac044

Ejemplares similares